Package 83324-099-24
Brand: migraine relief
Generic: acetaminophen, aspirin and caffeinePackage Facts
Identity
Package NDC
83324-099-24
Digits Only
8332409924
Product NDC
83324-099
Description
1 BOTTLE, PLASTIC in 1 CARTON (83324-099-24) / 24 TABLET in 1 BOTTLE, PLASTIC
Marketing
Marketing Status
Brand
migraine relief
Generic
acetaminophen, aspirin and caffeine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1ac6eaf4-0946-732a-e063-6394a90a303d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0635515998902"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["a6a07615-3108-436f-bbce-be7cb89ce456"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (83324-099-24) / 24 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "83324-099-24", "marketing_start_date": "20240501"}], "brand_name": "Migraine Relief", "product_id": "83324-099_1ac6eaf4-0946-732a-e063-6394a90a303d", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "83324-099", "generic_name": "ACETAMINOPHEN, ASPIRIN and CAFFEINE", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION, INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Migraine Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA214039", "marketing_category": "ANDA", "marketing_start_date": "20240501", "listing_expiration_date": "20261231"}